The cryptophycins as potent payloads for antibody drug conjugates
Graphical abstract
References and notes (35)
- et al.
Eur. J. Cancer
(2002) - et al.
Lung Cancer
(2003) - et al.
Blood
(2001) - et al.
J. Biol. Chem.
(2006) - et al.
Angew. Chem., Int. Ed.
(2014) - et al.
Targeted Oncol.
(2013) Br. J. Clin. Pharmacol.
(2013)- et al.
J. Pharm. Sci.
(2013) - et al.
Clin. Cancer Res.
(2011) - et al.
Engl. J. Med.
(2012)
J. Med. Chem.
(2014)
Curr. Opin. Oncol.
(2014)
J. Ind. Microbiol.
(1990)
Cancer Res.
(1994)
Synthesis
(2006)
Bioorg. Med. Chem.
(2014)
Cited by (44)
Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates
2024, European Journal of Medicinal ChemistryThe Evolving Landscape of Antibody-Drug Conjugates: In Depth Analysis of Recent Research Progress
2023, Bioconjugate ChemistryHarmful and beneficial properties of cyanotoxins: Two sides of the same coin
2023, Biotechnology AdvancesAntibody–drug conjugates: Recent advances in payloads
2023, Acta Pharmaceutica Sinica BCarbamate–drug conjugates in drug delivery: structural and mechanistic considerations
2023, Polymer-Drug Conjugates: Linker Chemistry, Protocols and ApplicationsFit-for-Purpose Synthesis of an Aza-Cryptophycin Analogue as the Payload for an Antibody-Drug Conjugate
2022, Organic Process Research and Development
Copyright © 2015 Elsevier Ltd. All rights reserved.